Lapse or Relapse to Drug Abuse and Other Chronic Conditions

The summary for the Lapse or Relapse to Drug Abuse and Other Chronic Conditions grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Lapse or Relapse to Drug Abuse and Other Chronic Conditions: The National Institute on Drug Abuse (NIDA) invites applications in which a behavioral, cognitive, social cognitive or neurobiological approach is used to advance our understanding of the causes, consequences and treatment of drug abuse relapse. The purpose of this RFA is to stimulate research that will lead to an improved understanding of the relapsing nature of drug addiction. This RFA particularly encourages interdisciplinary research that fosters collaboration between basic and applied researchers, between those studying humans in laboratory settings and those studying clinical populations. In addition, researchers who study other chronic, relapsing conditions (e.g., obesity, depression, anxiety disorders) are encouraged to apply their research approaches or paradigms to the problem of drug abuse and addiction. To the extent that relapse is a common feature of many chronic diseases, an understanding of drug abuse relapse will have considerable gene! ralizability beyond the phenomenon of drug addiction.
Federal Grant Title: Lapse or Relapse to Drug Abuse and Other Chronic Conditions
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DA-05-004
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse Research Programs
Current Application Deadline: No deadline provided
Original Application Deadline: Jan 18, 2005
Posted Date: Nov 09, 2004
Creation Date: Nov 09, 2004
Archive Date: Feb 17, 2005
Total Program Funding: $2,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 6
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments County governments City or township governments Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
Similar Government Grants
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical ...
Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R41/...
Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R43/...
Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders (R43/R44 C...
Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders (R41/R42 C...
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Research Project Grants in Pediatric Rehabilitation (R01 Clinical Trial Optional)
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical ...
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Cl...
Atopic Dermatitis Research Network Leadership Center (UM1) Clinical Trial Required
Atopic Dermatitis Research Network -Clinical Research Centers (U01 Clinical Trial Optional...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com